BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31209661)

  • 1. Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
    Mendoza TR; Williams LA; Keating KN; Siegel J; Elbi C; Nowak AK; Hassan R; Cuffel B; Cleeland CS
    J Patient Rep Outcomes; 2019 Jun; 3(1):34. PubMed ID: 31209661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
    Williams LA; Whisenant MS; Mendoza TR; Haq S; Keating KN; Cuffel B; Cleeland CS
    Qual Life Res; 2018 Dec; 27(12):3229-3241. PubMed ID: 30187393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
    Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
    Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
    Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
    Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
    Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group.
    Jones D; Zhao F; Fisch MJ; Wagner LI; Patrick-Miller LJ; Cleeland CS; Mendoza TR
    Clin Genitourin Cancer; 2014 Feb; 12(1):41-9. PubMed ID: 24126238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
    Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
    Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
    Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
    Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
    J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.
    Sailors MH; Bodurka DC; Gning I; Ramondetta LM; Williams LA; Mendoza TR; Agarwal S; Sun CC; Cleeland CS
    Gynecol Oncol; 2013 Aug; 130(2):323-8. PubMed ID: 23685012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Spanish version of the MD Anderson symptom inventory - heart failure (MDASI-HF-Spanish) module.
    Fadol A; Buitrago J; Diaz MC; Shelton V; Harty C; Mendoza TR
    Cardiooncology; 2019; 5():19. PubMed ID: 32154025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso.
    Hollen PJ; Gralla RJ; Liepa AM; Symanowski JT; Rusthoven JJ
    Support Care Cancer; 2006 Jan; 14(1):11-21. PubMed ID: 15999264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C).
    Chen RW; Yang SL; Xu ZY; Peng M; Chen MN; Wang QS; Chang J; Hu JL
    J Pain Symptom Manage; 2019 Apr; 57(4):820-827. PubMed ID: 30684634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID).
    Williams LA; Whisenant MS; Mendoza TR; Peek AE; Malveaux D; Griffin DK; Ponce DA; Granwehr BP; Sheshadri A; Hutcheson KA; Ali SM; Peterson SK; Heymach JV; Cleeland CS; Subbiah IM
    J Patient Rep Outcomes; 2023 May; 7(1):48. PubMed ID: 37237077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and Application of MD Anderson Symptom Inventory Module for Patients with Bladder Cancer in the Perioperative Setting.
    Kamal M; Navai N; Bree KK; Williams LA; Cleeland CS; Shen SE; Wang XS
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.
    Nejmi M; Wang XS; Mendoza TR; Gning I; Cleeland CS
    J Pain Symptom Manage; 2010 Jul; 40(1):75-86. PubMed ID: 20619213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric validity and reliability of the Danish version of the MD Anderson Symptom Inventory Brain Tumor Module.
    Piil K; Whisenant M; Mendoza T; Armstrong T; Cleeland C; Nordentoft S; Williams LA; Jarden M
    Neurooncol Pract; 2021 Apr; 8(2):137-147. PubMed ID: 33898047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Psychometric Evaluation of the Chinese Version of the M.D. Anderson Symptom Inventory-Heart Failure in Chinese Cancer Patients With Concurrent Heart Failure.
    Chair SY; Wang Q; Yu M; Kwok Wei So W; Tian C; Wing Hung Sit J; Mi Ling Wong E; Wing Han Chan C; Fadol A
    Rehabil Nurs; 2017; 42(6):354-361. PubMed ID: 29244037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep.
    Wang XS; Shi Q; Williams LA; Lillemoe HA; Chen TY; Gottumukkala V; Garcia-Gonzalez A; Malveaux D; Kamal M; Cleeland CS; Aloia TA
    Eur J Oncol Nurs; 2021 Jun; 52():101959. PubMed ID: 33964632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language.
    Sánchez D; Chala A; Alvarez A; Payan C; Mendoza T; Cleeland C; Sanabria A
    J Pain Symptom Manage; 2016 Jun; 51(6):1055-61. PubMed ID: 26899822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.